Physician profile
Dunia Perez
NPI 1922502483
$2,478.14
in general payments reported to CMS, 2019-2025
16 companies · $2,190 in 2025
The $2,190 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.93 · 2024: $237 · 2025: $2,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,427.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $570.67 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $405.98 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Phathom Pharmaceuticals, INC. | $290.31 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.97 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $206.74 | 2024-2025 | Mounjaro, Jardiance |
| Amgen INC. | $174.18 | 2024-2025 | Otezla, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.32 | 2024-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $119.43 | 2025 | Nucala |
| Amneal Pharmaceuticals LLC | $81.69 | 2025 | Unithroid |
| Pfizer INC. | $70.36 | 2025 | |
| Janssen Pharmaceuticals, INC | $50.93 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.08 | 2025 | |
| Evoke Pharma, INC. | $22.77 | 2025 | |
| Ironwood Pharmaceuticals, INC | $22.37 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.29 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dunia Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.